Friday 7/2 Insider Buying Report: CVM, VYNT

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

On Monday, CEL-SCI's Director, Peter R.

Young, made a $37,971 purchase of CVM, buying 3,000 shares at a cost of $12.66 a piece.

Investors have the opportunity to buy CVM at a price even lower than Young did, with shares trading as low as $7.77 at last check today which is 38.6% below Young's purchase price.

CEL-SCI Corporation is trading down about 10.1% on the day Friday.

Before this latest buy, Young bought CVM at 3 other times during the past twelve months, for a total cost of $44,827 at an average of $11.49 per share.

And at Vyant Bio, there was insider buying on Wednesday, by Director Marcus Boehm who bought 10,000 shares for a cost of $3.72 each, for a trade totaling $37,224.

This buy marks the first one filed by Boehm in the past year.

Vyant Bio is trading down about 1.1% on the day Friday.